Exact Mass: 555.2303988000001
Exact Mass Matches: 555.2303988000001
Found 159 metabolites which its exact mass value is equals to given mass value 555.2303988000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Rociletinib
C27H28F3N7O3 (555.2205614000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid
C32H33N3O6 (555.2369238000001)
Glu Arg His Asp
Cys Phe Met Arg
Cys Phe Arg Met
Cys Met Phe Arg
Cys Met Arg Phe
Cys Arg Phe Met
Cys Arg Met Phe
Asp Glu His Arg
Asp Glu Arg His
Asp Phe Phe Gln
Asp Phe Gln Phe
Asp His Glu Arg
Asp His Arg Glu
Asp Lys Met Tyr
Asp Lys Tyr Met
Asp Met Lys Tyr
Asp Met Tyr Lys
Asp Gln Phe Phe
Asp Arg Glu His
Asp Arg His Glu
Asp Tyr Lys Met
Asp Tyr Met Lys
Glu Asp His Arg
Glu Asp Arg His
Glu Phe Phe Asn
Glu Phe Asn Phe
Glu His Asp Arg
Glu His Arg Asp
Glu Asn Phe Phe
Glu Arg Asp His
Phe Cys Met Arg
Phe Cys Arg Met
Phe Asp Phe Gln
Phe Asp Gln Phe
Phe Glu Phe Asn
Phe Glu Asn Phe
Phe Phe Asp Gln
Phe Phe Glu Asn
Phe Phe Asn Glu
Phe Phe Gln Asp
Phe Met Cys Arg
Phe Met Arg Cys
Phe Asn Glu Phe
Phe Asn Phe Glu
Phe Gln Asp Phe
Phe Gln Phe Asp
Phe Arg Cys Met
Phe Arg Met Cys
His Asp Glu Arg
His Asp Arg Glu
His Glu Asp Arg
His Glu Arg Asp
His Arg Asp Glu
His Arg Glu Asp
Lys Asp Met Tyr
Lys Asp Tyr Met
Lys Met Asp Tyr
Lys Met Tyr Asp
Lys Tyr Asp Met
Lys Tyr Met Asp
Met Cys Phe Arg
Met Cys Arg Phe
Met Asp Lys Tyr
Met Asp Tyr Lys
Met Phe Cys Arg
Met Phe Arg Cys
Met Lys Asp Tyr
Met Lys Tyr Asp
Met Arg Cys Phe
Met Arg Phe Cys
Met Tyr Asp Lys
Met Tyr Lys Asp
Asn Glu Phe Phe
Asn Phe Glu Phe
Asn Phe Phe Glu
Asn Pro Tyr Tyr
Asn Tyr Pro Tyr
Asn Tyr Tyr Pro
Pro Asn Tyr Tyr
Pro Tyr Asn Tyr
Pro Tyr Tyr Asn
Gln Asp Phe Phe
Gln Phe Asp Phe
Gln Phe Phe Asp
Arg Cys Phe Met
Arg Cys Met Phe
Arg Asp Glu His
Arg Asp His Glu
Arg Glu Asp His
Arg Glu His Asp
Arg Phe Cys Met
Arg Phe Met Cys
Arg His Asp Glu
Arg His Glu Asp
Arg Met Cys Phe
Arg Met Phe Cys
Ser Thr Trp Tyr
Ser Thr Tyr Trp
Ser Trp Thr Tyr
Ser Trp Tyr Thr
Ser Tyr Thr Trp
Ser Tyr Trp Thr
Thr Ser Trp Tyr
Thr Ser Tyr Trp
Thr Trp Ser Tyr
Thr Trp Tyr Ser
Thr Tyr Ser Trp
Thr Tyr Trp Ser
Trp Ser Thr Tyr
Trp Ser Tyr Thr
Trp Thr Ser Tyr
Trp Thr Tyr Ser
Trp Tyr Ser Thr
Trp Tyr Thr Ser
Tyr Asp Lys Met
Tyr Asp Met Lys
Tyr Lys Asp Met
Tyr Lys Met Asp
Tyr Met Asp Lys
Tyr Met Lys Asp
Tyr Asn Pro Tyr
Tyr Asn Tyr Pro
Tyr Pro Asn Tyr
Tyr Pro Tyr Asn
Tyr Ser Thr Trp
Tyr Ser Trp Thr
Tyr Thr Ser Trp
Tyr Thr Trp Ser
Tyr Trp Ser Thr
Tyr Trp Thr Ser
Tyr Tyr Asn Pro
Tyr Tyr Pro Asn
N-(Ethylsulfonyl)tryptophyl-N~1~-{4-[amino(imino)methyl]benzyl}glutamamide
4-[2-Acetylamino-2-(1-biphenyl-4-ylmethyl-2-oxo-azepan-3-ylcarbamoyl)-ethyl]-2-formyl-benzoic acid
C32H33N3O6 (555.2369238000001)
Rociletinib
C27H28F3N7O3 (555.2205614000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(2R)-3-hydroxy-2-{[6-O-(6-O-octanoyl-alpha-D-glucopyranosyl)-alpha-D-glucopyranosyl]oxy}propanoate
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[[(1S,2R,4R,7Z,11S)-4,8-dimethyl-13-oxo-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-12-yl]methylsulfanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
C25H37N3O9S (555.2250392000001)
2-O-[6-O-Octanoyl-alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate
(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C31H33N5O3S (555.2303988000001)
N-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4S,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4S,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4R,5R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
N-[[(4R,5S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
C29H37N3O6S (555.2402942000001)
(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C31H33N5O3S (555.2303988000001)
3-vinylbacteriochlorophyllide d(1-)
A cyclic tetrapyrrole anion that is the conjugate base of 3-vinylbacteriochlorophyllide d, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(3r)-n-[(2s,4e)-6-amino-1-oxohex-4-en-2-yl]-3-cyano-3-{[4-(4-{[1-hydroxy-2-(n'-hydroxycarbamimidamido)ethylidene]amino}-1h-pyrrole-2-amido)-1h-pyrrol-2-yl]formamido}propanimidic acid
2-oxo-n-{[(1r,2s,10r,13r,14s)-14,16,19-trihydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15,17,19-pentaen-10-yl]methyl}propanamide
C28H33N3O9 (555.2216688000001)